Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. 2002

Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.

The low density lipoprotein receptor-related protein (LRP-1) binds and mediates the endocytosis of multiple ligands, transports the urokinase-type plasminogen activator receptor (uPAR) and other membrane proteins into endosomes, and binds intracellular adaptor proteins involved in cell signaling. In this paper, we show that in murine embryonic fibroblasts (MEFs) and L929 cells, LRP-1 functions as a major regulator of Rac1 activation, and that this activity depends on uPAR. LRP-1-deficient MEFs demonstrated increased Rac1 activation compared with LRP-1-expressing MEFs, and this property was reversed by expressing the VLDL receptor, a member of the same gene family as LRP-1, with overlapping ligand-binding specificity. Neutralizing the activity of LRP-1 with receptor-associated protein (RAP) increased Rac1 activation and cell migration in MEFs and L929 cells. The same parameters were unaffected by RAP in uPAR-/- MEFs, prepared from uPAR gene knockout embryos, and in uPAR-deficient LM-TK- cells. Untreated uPAR+/+ MEFs demonstrated substantially increased Rac1 activation compared with uPAR-/- MEFs. In addition to Rac1, LRP-1 suppressed activation of extracellular signal-regulated kinase (ERK) in MEFs; however, it was Rac1 (and not ERK) that was responsible for the effects of LRP-1 on MEF migration. Thus, LRP-1 regulates two signaling proteins in the same cell (Rac1 and ERK), both of which may impact on cell migration. In uPAR-negative cells, LRP-1 neutralization does not affect Rac1 activation, and other mechanisms by which LRP-1 may regulate cell migration are not unmasked.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008856 Microscopy, Fluorescence Microscopy of specimens stained with fluorescent dye (usually fluorescein isothiocyanate) or of naturally fluorescent materials, which emit light when exposed to ultraviolet or blue light. Immunofluorescence microscopy utilizes antibodies that are labeled with fluorescent dye. Fluorescence Microscopy,Immunofluorescence Microscopy,Microscopy, Immunofluorescence,Fluorescence Microscopies,Immunofluorescence Microscopies,Microscopies, Fluorescence,Microscopies, Immunofluorescence
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
March 2013, Cellular and molecular neurobiology,
Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
June 2004, Thrombosis and haemostasis,
Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
October 2021, Developmental cell,
Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
November 1998, Trends in cardiovascular medicine,
Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
June 1996, Biochimica et biophysica acta,
Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
March 2014, Arteriosclerosis, thrombosis, and vascular biology,
Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
April 2000, Cancer research,
Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
May 2018, Cellular and molecular life sciences : CMLS,
Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
January 1983, The International journal of biochemistry,
Zhong Ma, and Keena S Thomas, and Donna J Webb, and Radim Moravec, and Ana Maria Salicioni, and Wendy M Mars, and Steven L Gonias
March 1993, The Journal of clinical investigation,
Copied contents to your clipboard!